Some studies suggested that BRCA1 pathogenic variants tend to be associated with aggressive prostate cancer (OR = 1.2–2.0); however, the lower carrier frequency of BRCA1 (0.2%) compared with BRCA2 (1.1%) limits the statistical power. The gene discussed is BRCA2; the disease is Familial prostate cancer.